Cargando…

Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer

PURPOSE: This study aimed to identify the prognostic value of early metabolic response assessed using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) during radiation therapy (RT) for cervical cancer. MATERIALS AND METHODS: We identified 116 patients treated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Nalee, Park, Won, Cho, Won Kyung, Bae, Duk-Soo, Kim, Byoung-Gie, Lee, Jeong-Won, Kim, Tae-Joong, Choi, Chel Hun, Lee, Yoo-Young, Cho, Young Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291185/
https://www.ncbi.nlm.nih.gov/pubmed/33321566
http://dx.doi.org/10.4143/crt.2020.1251
_version_ 1783724599619354624
author Kim, Nalee
Park, Won
Cho, Won Kyung
Bae, Duk-Soo
Kim, Byoung-Gie
Lee, Jeong-Won
Kim, Tae-Joong
Choi, Chel Hun
Lee, Yoo-Young
Cho, Young Seok
author_facet Kim, Nalee
Park, Won
Cho, Won Kyung
Bae, Duk-Soo
Kim, Byoung-Gie
Lee, Jeong-Won
Kim, Tae-Joong
Choi, Chel Hun
Lee, Yoo-Young
Cho, Young Seok
author_sort Kim, Nalee
collection PubMed
description PURPOSE: This study aimed to identify the prognostic value of early metabolic response assessed using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) during radiation therapy (RT) for cervical cancer. MATERIALS AND METHODS: We identified 116 patients treated with definitive RT, including FDG-PET/CT–guided intracavitary brachytherapy, between 2009 and 2018. We calculated parameters including maximum (SUV(max)) and mean standardized uptake values (SUV(mean)), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) for baseline FDG-PET/CT (PET(base)) and image-guided brachytherapy planning FDG-PET/CT (PET(IGBT)). Multivariable analyses of disease-free survival (DFS) and overall survival (OS) were performed. RESULTS: We observed a time-dependent decrease in PET parameters between PET(base) and PET(IGBT); ΔSUV(max), ΔSUV(mean), ΔMTV, and ΔTLG were 65%, 61%, 78%, and 93%, respectively. With a median follow-up of 59.5 months, the 5-year DFS and OS rates were 66% and 79%, respectively. Multivariable analysis demonstrated that ΔSUV(max) ≥ 50% was associated with favorable DFS (hazard ratio [HR], 2.56; 95% confidence interval [CI], 1.14 to 5.77) and OS (HR, 5.14; 95% CI, 1.55 to 17.01). Patients with ΔSUV(max) ≥ 50% (n=87) showed better DFS and OS than those with ΔSUV(max) < 50% (n=29) (DFS, 76% vs. 35%, p < 0.001; OS, 90% vs. 41%, p < 0.001, respectively). Adenocarcinoma was frequently observed in ΔSUV(max) < 50% compared to ΔSUV(max) ≥ 50% (27.6% vs. 10.3%, p=0.003). In addition, models incorporating metabolic parameters showed improved accuracy for predicting DFS (p=0.012) and OS (p=0.004) than models with clinicopathologic factors. CONCLUSION: Changes in metabolic parameters, especially those in SUV(max) by > 50%, can help improve survival outcome predictions for patients with cervical cancer treated with definitive RT.
format Online
Article
Text
id pubmed-8291185
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-82911852021-08-04 Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer Kim, Nalee Park, Won Cho, Won Kyung Bae, Duk-Soo Kim, Byoung-Gie Lee, Jeong-Won Kim, Tae-Joong Choi, Chel Hun Lee, Yoo-Young Cho, Young Seok Cancer Res Treat Original Article PURPOSE: This study aimed to identify the prognostic value of early metabolic response assessed using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) during radiation therapy (RT) for cervical cancer. MATERIALS AND METHODS: We identified 116 patients treated with definitive RT, including FDG-PET/CT–guided intracavitary brachytherapy, between 2009 and 2018. We calculated parameters including maximum (SUV(max)) and mean standardized uptake values (SUV(mean)), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) for baseline FDG-PET/CT (PET(base)) and image-guided brachytherapy planning FDG-PET/CT (PET(IGBT)). Multivariable analyses of disease-free survival (DFS) and overall survival (OS) were performed. RESULTS: We observed a time-dependent decrease in PET parameters between PET(base) and PET(IGBT); ΔSUV(max), ΔSUV(mean), ΔMTV, and ΔTLG were 65%, 61%, 78%, and 93%, respectively. With a median follow-up of 59.5 months, the 5-year DFS and OS rates were 66% and 79%, respectively. Multivariable analysis demonstrated that ΔSUV(max) ≥ 50% was associated with favorable DFS (hazard ratio [HR], 2.56; 95% confidence interval [CI], 1.14 to 5.77) and OS (HR, 5.14; 95% CI, 1.55 to 17.01). Patients with ΔSUV(max) ≥ 50% (n=87) showed better DFS and OS than those with ΔSUV(max) < 50% (n=29) (DFS, 76% vs. 35%, p < 0.001; OS, 90% vs. 41%, p < 0.001, respectively). Adenocarcinoma was frequently observed in ΔSUV(max) < 50% compared to ΔSUV(max) ≥ 50% (27.6% vs. 10.3%, p=0.003). In addition, models incorporating metabolic parameters showed improved accuracy for predicting DFS (p=0.012) and OS (p=0.004) than models with clinicopathologic factors. CONCLUSION: Changes in metabolic parameters, especially those in SUV(max) by > 50%, can help improve survival outcome predictions for patients with cervical cancer treated with definitive RT. Korean Cancer Association 2021-07 2020-12-09 /pmc/articles/PMC8291185/ /pubmed/33321566 http://dx.doi.org/10.4143/crt.2020.1251 Text en Copyright © 2021 by the Korean Cancer Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Nalee
Park, Won
Cho, Won Kyung
Bae, Duk-Soo
Kim, Byoung-Gie
Lee, Jeong-Won
Kim, Tae-Joong
Choi, Chel Hun
Lee, Yoo-Young
Cho, Young Seok
Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer
title Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer
title_full Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer
title_fullStr Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer
title_full_unstemmed Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer
title_short Early Metabolic Response Assessed Using (18)F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer
title_sort early metabolic response assessed using (18)f-fdg-pet/ct for image-guided intracavitary brachytherapy can better predict treatment outcomes in patients with cervical cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291185/
https://www.ncbi.nlm.nih.gov/pubmed/33321566
http://dx.doi.org/10.4143/crt.2020.1251
work_keys_str_mv AT kimnalee earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer
AT parkwon earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer
AT chowonkyung earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer
AT baeduksoo earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer
AT kimbyounggie earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer
AT leejeongwon earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer
AT kimtaejoong earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer
AT choichelhun earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer
AT leeyooyoung earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer
AT choyoungseok earlymetabolicresponseassessedusing18ffdgpetctforimageguidedintracavitarybrachytherapycanbetterpredicttreatmentoutcomesinpatientswithcervicalcancer